Stoke Therapeutics Cash from Investing (TTM) Analysis

Stoke Therapeutics Inc (STOK)

12.01 +0.32 (+2.74%) USD | NASDAQ | May 03, 14:55

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	105.95M
September 30, 2023	113.66M
June 30, 2023	166.31M
March 31, 2023	142.98M
December 31, 2022	-45.88M
September 30, 2022	-56.58M
June 30, 2022	-129.10M
March 31, 2022	-212.00M
December 31, 2021	-76.43M
September 30, 2021	-88.31M
June 30, 2021	-83.32M

Date	Value
March 31, 2021	-0.644M
December 31, 2020	-1.05M
September 30, 2020	-1.529M
June 30, 2020	-1.843M
March 31, 2020	-2.154M
December 31, 2019	-1.634M
September 30, 2019	-1.148M
June 30, 2019	-1.081M
March 31, 2019	-0.989M
December 31, 2018	-0.925M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-212.00M

Minimum

Mar 2022

166.31M

Maximum

Jun 2023

-9.147M

Average

-1.634M

Median

Dec 2019

Cash from Investing (TTM) Benchmarks